We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.7%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$2.26B
(+9%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
24.36%
Holding
1,897
New
97
Increased
682
Reduced
737
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$28.3M |
| 2 |
Allstate
ALL
|
+$25.8M |
| 3 |
Intuitive Surgical
ISRG
|
+$19.6M |
| 4 |
Neogen
NEOG
|
+$17.4M |
| 5 |
DoubleVerify
DV
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$29.1M |
| 2 |
Planet Fitness
PLNT
|
+$20.4M |
| 3 |
Airbnb
ABNB
|
+$17.1M |
| 4 |
IBM
IBM
|
+$14.8M |
| 5 |
Xometry
XMTR
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.59% |
| 2 | Healthcare | 18.44% |
| 3 | Industrials | 11.64% |
| 4 | Financials | 11.51% |
| 5 | Consumer Discretionary | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
1151
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $380K | ﹤0.01% |
9,029
-1,652
| -15% | -$66.8K |
|
1152
Mitsubishi UFJ Financial
MUFG
$260B
| $380K | ﹤0.01% |
51,556
-3,229
| -6% | -$21.5K |
|
1153
Intellia Therapeutics
NTLA
$1.66B
| $377K | ﹤0.01% |
9,250
+2,000
| +28% | +$81.1K |
|
1154
Aptiv
APTV
$10.2B
| $376K | ﹤0.01% |
3,680
-1,376
| -27% | -$136K |
|
1155
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.98B
| $375K | ﹤0.01% |
11,022
| – | – |
|
1156
Traeger
COOK
$166M
| $375K | ﹤0.01% |
1,764
-123
| -7% | -$22.2K |
|
1157
Peloton Interactive
PTON
$2.44B
| $374K | ﹤0.01% |
48,670
+4,326
| +10% | +$36.8K |
|
1158
CMS Energy
CMS
$22.1B
| $374K | ﹤0.01% |
6,361
-444
| -7% | -$26.8K |
|
1159
XPO
XPO
$24.7B
| $373K | ﹤0.01% |
6,330
-300
| -5% | -$13.6K |
|
1160
MGE Energy Inc
MGEE
$3.06B
| $373K | ﹤0.01% |
4,717
| – | – |
|
1161
TaskUs
TASK
$667M
| $373K | ﹤0.01% |
32,916
-715
| -2% | -$8.7K |
|
1162
ProShares Ultra S&P500
SSO
$8.51B
| $372K | ﹤0.01% |
12,800
| – | – |
|
1163
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.09B
| $372K | ﹤0.01% |
46,938
| – | – |
|
1164
Spire
SR
$4.9B
| $372K | ﹤0.01% |
5,857
-523
| -8% | -$35.1K |
|
1165
Invitation Homes
INVH
$18B
| $370K | ﹤0.01% |
10,750
-60
| -0.6% | -$2K |
|
1166
Expedia Group
EXPE
$39.4B
| $370K | ﹤0.01% |
3,378
-92
| -3% | -$9.02K |
|
1167
Camping World
CWH
$675M
| $366K | ﹤0.01% |
12,150
-2,000
| -14% | -$50.4K |
|
1168
STAG Industrial
STAG
$7.12B
| $365K | ﹤0.01% |
10,165
-9,280
| -48% | -$321K |
|
1169
Revolve Group
RVLV
$1.72B
| $365K | ﹤0.01% |
22,237
-700
| -3% | -$13K |
|
1170
Universal Display
OLED
$4.18B
| $365K | ﹤0.01% |
2,530
-250
| -9% | -$35.8K |
|
1171
Under Armour
UAA
$2.3B
| $364K | ﹤0.01% |
50,463
-7,541
| -13% | -$60.7K |
|
|
VPU
1172
Vanguard Utilities ETF
VPU
$8.52B
| $364K | ﹤0.01% |
2,561
+522
| +26% | +$76.5K |
|
|
HZNP
1173
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $362K | ﹤0.01% |
3,521
+205
| +6% | +$21.6K |
|
|
VLD
1174
DELISTED
Velo3D, Inc.
VLD
| $362K | ﹤0.01% |
4,787
-992
| -17% | -$69.2K |
|
1175
Globe Life
GL
$14B
| $360K | ﹤0.01% |
3,287
+418
| +15% | +$44.9K |
|
Similar funds
HF
William Blair & Company's Q2 2023 Portfolio in Review
As of Q2 2023, William Blair & Company held 1,897 positions worth $27.3B, up 9% from $25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
William Blair & Company's Q2 2023 filing shows 97 new, 682 increased, 737 reduced and 88 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M. The largest sale was Neurocrine Biosciences, an estimated $29.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- William Blair & Company's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M.
- William Blair & Company added most to Costco in Q2 2023, an estimated $28.3M increase.
- William Blair & Company's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $29.1M.
- William Blair & Company fully exited ABB Ltd in Q2 2023, selling an estimated $7.21M.
- William Blair & Company's ten largest holdings make up 24% of its $27.3B portfolio in Q2 2023.
- William Blair & Company opened 97 new positions and closed 88 in Q2 2023.
- William Blair & Company's portfolio value rose 9% quarter-over-quarter to $27.3B.
Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.